A fibronectin-like molecule is present in the developing cat cerebral cortex and is correlated with subplate neurons by unknown
A Fibronectin-like Molecule Is Present in the Developing Cat 
Cerebral Cortex and Is Correlated with Subplate Neurons 
Jerold J. M. Chun and Carla J. Shatz 
Department of Neurobiology, Stanford University School of Medicine, Stanford, California 94305 
Abstract.  The subplate is a transient  zone of the de- 
veloping cerebral cortex through which postmitotic 
neurons migrate and growing axons elongate en route 
to their adult positions within the cortical plate.  To 
learn more about the cellular interactions that occur in 
this zone,  we have examined whether fibronectins 
(FNs), a family of molecules known to promote mi- 
gration and elongation in other systems, are present 
during the fetal and postnatal development of the cat's 
cerebral cortex. Three different anti-FN antisera recog- 
nized a single broad band with an apparent molecular 
mass of 200-250 kD in antigen-transfer analyses (re- 
ducing conditions) of plasma-depleted (perfused) whole 
fetal brain or synaptosome preparations,  indicating that 
FNs are present at these ages. This band can be de- 
tected as early as  1 mo before birth at embryonic day 
39.  Immunohistochemical  examination of the develop- 
ing cerebral cortex from animals between embryonic 
day 46 and postnatal day 7 using any of the three an- 
tisera revealed that FN-like immunoreactivity is re- 
stricted to the subplate and the marginal  zones, and is 
not found in the cortical plate.  As these zones mature 
into their adult counterparts (the white matter and 
layer 1 of the cerebral cortex), immunostaining gradually 
disappears and is not detectable by postnatal day 70. 
Previous studies have shown that the subplate and 
marginal zones contain a  special, transient population 
of neurons (Chun, J. J.  M., M. J.  Nakamura,  and 
C. J.  Shatz.  1987. Nature (Lond.).  325:617-620).  The 
FN-like immunostaining  in the subplate and marginal 
zone is closely associated with these neurons,  and 
some of the immunostaining  delineates them.  More- 
over, the postnatal disappearance of FN-like immuno- 
staining  from the subplate is correlated spatially and 
temporally with the disappearance of the subplate neu- 
rons.  When subplate neurons are killed by neuro- 
toxins, FN-like immunostaining  is depleted in the le- 
sioned area.  These observations show that an FN-like 
molecule is present transiently  in the subplate of the 
developing cerebral cortex and,  further,  is spatially 
and temporally correlated with the transient  subplate 
neurons.  The presence of FNs within this zone, but 
not in the cortical plate, suggests that the extracellular 
milieu of the subplate mediates a unique set of interac- 
tions required for the development of the cerebral 
cortex. 
T 
HE mammalian cerebral cortex, the multilayered struc- 
ture  of the paired  cerebral hemispheres,  is derived 
from a simple neural tube. During fetal development, 
the proximal portion of the tube (the telencephalon)  expands 
through  successive cell division and migration,  giving rise 
to the cerebral hemispheres.  The location of the telencepha- 
Ion is shown schematically  in Fig.  1 A (TEL), a horizontal 
section through  the embryonic central  nervous system. The 
cellular organization of the developing telencephalon  is very 
different  from that  found in the adult,  and several distinct 
embryonic zones have been identified (see Fig.  1 and Boul- 
der Committee,  1970). 
Two of these embryonic zones, the subplate and marginal 
zones, are remarkable for several cellular elements and inter- 
actions that occur there.  Positioned in the subplate and mar- 
ginal zones is a special population  of cells, the subplate and 
marginal  zone cells. They are the earliest generated  cells of 
the  telencephalon,  having  undergone  their  last  round  of 
DNA synthesis and cell division between embryonic days (E) ~ 
24 and 30 in the cat (gestation  is 65 d in the cat) based on 
[3H]thymidine  administration  (Luskin  and  Shatz,  1985a; 
see Materials  and Methods). Initially forming a single band 
within the developing cerebral cortex, the population is sub- 
sequently split apart by intervening cells destined for the var- 
ious layers of the adult cortex. Thus,  cells from the same 
early generated population take residence in the subplate and 
marginal  zones.  During  fetal life, these cells are present in 
large numbers in the subplate (and to a lesser extent in the 
marginal zone) but disappear postnatally as the subplate ma- 
tures into the white matter (and the marginal  zone matures 
into cortical layer 1) of the adult (Luskin and Shatz,  1985a). 
The subplate and marginal  zone cells are neurons based on 
ultrastructural,  neuroanatomical,  and immunohistochemical 
t. Abbreviations  used in this paper:  E, embryonic day;  FN, fibronectin; 
GFAP, glial fibriUary acidic protein; MAP2, microtubule-associated  protein 
2; P, postnatal  day. 
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shown in a schematic drawing (horizontal plane of section) in A. 
The telencephalon (TEL) includes two symmetric lobes (the cere- 
bral hemispheres), which enclose the ventricles (V) containing ce- 
rebral spinal fluid and the choroid plexus. Further posterior are the 
diencephalon (DI), mesencephalon (MES), myelencephalon (MY), 
and spinal cord (SC). (OC, optic cup). (B) An enlargement of the 
region enclosed in the box of  A* shows that during development the 
telencephalic wall can be subdivided into several embryonic zones. 
Closest to the ventricle (V) is the ventricular zone (l/Z) or future 
ependyma. Next is the intermediate zone (/Z) the future white mat- 
ter, that contains as a subdivision the subplate zone (SP) indicated 
by shading. The subplate is subjacent to the cortical plate (CP) or 
future cortex. Immediately above the cortical plate is the marginal 
zone (MZ) or future layer 1. The pial (P) surface of the brain is 
outermost.  A, anterior;  P, posterior;  M, medial; L, lateral. 
data (Chun et al.,  1987); many of them are immunoreactive 
for neuropeptides, and all are immunoreactive for the neuron- 
specific protein microtubule-associated protein 2  (MAP2; 
Chun et al.,  1987; see Figs.  8 and 9). 
The subplate also contains other postmitotic neurons that, 
having undergone their final round of DNA synthesis at the 
ventricular zone, are migrating en route to the cortical plate. 
These cells must pass through the subplate, apparently mov- 
ing along radial glia positioned there (Rakic,  1972). Many 
growing axonal systems also pass through the subplate to ul- 
timately innervate their cortical targets.  In so doing,  these 
developing axonal systems do not directly innervate the corti- 
cal plate, but rather wait for several weeks within the sub- 
plate  before  finally  growing  into  the  cortical  plate  itself 
(Rakic, 1977; Lurid and Mustari, 1977; Wise and Jones, 1978; 
CrandaU  and  Caviness,  1984;  Shatz  and  Luskin,  1986). 
Amongst these waiting afferents are found transient synapses 
that also disappear from the subplate when afferent systems 
grow into the cortical plate (Molliver et al.,  1973; Kostovic 
and Molliver,  1974; Cragg,  1975). The presence of the sub- 
plate (and marginal zone) neuron is therefore correlated with 
the presence of migrating neurons, waiting axons, and tran- 
sient synapses. 
Since  the  subplate  is  a  region  in  which  extensive  cell 
migration  and axon elongation occurs,  it may contain  ex- 
tracellular matrix molecules essential  for these  functions. 
One such family of molecules are the adhesive glycoproteins 
known  as  fibronectins  (FNs;  Hynes  and  Yamada,  1982; 
Hynes, 1985).  In other systems, FNs can promote a variety 
of cellular events such as cell migration (Hynes and Yamada, 
1982;  Hynes 1985;  Thiery and Duband,  1986) and neurite 
extension (Akers, 1981; Rogers et al.,  1983, 1985). However, 
it is uncertain whether FNs are present within the developing 
brain, and if so, whether they are found in the correct neu- 
roanatomical locations at the appropriate times to mediate 
functions such as cell migration or axon elongation. Several 
previous immunohistochemical studies addressed the pres- 
ence of FNs by examining the developing rodent brain, but 
the results have been contradictory (FN was not detected by 
Schachner  et al.,  1978; Minier  et al.,  1981; Hynes et al., 
1986;  but  see Hatten et al.,  1982;  Stewart and  Pearlman, 
1987). Here we have investigated whether FN-like molecules 
are  present  during  the  development of the  cat's brain  by 
means of antigen-transfer analysis and immunohistochemis- 
try. We were especially interested in examining the subplate 
and marginal zones in view of the wealth of available infor- 
mation mentioned above indicating the presence of develop- 
mental events that could be mediated by extracellular matrix 
molecules. The prolonged time course of development in the 
cat as compared with rodents increased the likelihood that 
such molecules could be detected. In particular, we wished 
to examine whether the subplate and marginal zone neurons 
might be correlated with the regulation and/or expression of 
this extracellular matrix molecule during development. 
Materials and Methods 
41 cat brains between  the ages  of E39 (gestation  is 65 d) and adulthood were 
examined using immunohistochemical  techniques combined  with [3H]thy- 
midine autoradiography. These two approaches  were also combined with 
neurotoxin injections. Table I summarizes  the experimental  permutations 
used. Fetal ages were determined by timed breedings as described previ- 
ously (Luskin and Shatz, 1985a). 
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Age* at  No.  Antigen-transfer  Immunohisto- 
examination  of animals  analysis  chemistry 
E39  1  + 
E46'  1  + 
EA8  1  + 
E50  2  + 
E50*  2  + 
E52  2  + 
E54  1  + 
E56  1  + 
E56'  2  + 
P1  1  + 
P7  1  + 
P7*  1  + 
P7  1  + 
P21  1  + 
P28'  1  + 
P49'  1  + 
P70  1  + 
P178'  1  + 
P401 (ADULT)*  1  + 
ADULT  1  + 
ADULT  2  + 
* E, Embryonic day (65-d gestation); P, postnatal day. 
~t [3H]thymidine  was administered at E27 and tissue autoradiographed at the 
examination age. 
Surgical Procedure 
All procedures included sterile surgical technique to externalize fetuses by 
cesarian section for study. Pregnant cats in which fetuses were of known 
gestational age were initially anesthetized by inhalation of halothane (1-2 % 
in O~) or by intramuscular injection of ketamine hydrochioride (20 mg/kg) 
and acepromazine (0.2 mg/kg). Anesthesia was maintained by halothane 
(0.5-2% in Oz) administered through an endotrachial tube, and the appro- 
priate level was monitored by ventilation and heart rate.  A  5 % dextrose/ 
saline i.v. drip was maintained throughout the surgery. Terbutaline sulfate 
was administered (0.03 mg/kg i.v. ) before each fetal manipulation. After sur- 
gery, the animals were given analgesics and monitored in the 24-h/d inten- 
sive care unit for at least 36 h. Further details of the surgical procedure can 
be found in Luskin and Shatz,  1985a. 
Injections 
The subplate and marginal zone neurons were identified by labeling them 
on their birthdates with an intrauterine injection of [3H]thymidine (NET 
O27Z, 76.1 Ci/mmol; DuPont Co., Wilmington, DE) delivered on E27 or 
E28, a time well before neurons of the adult cortical layers are generated 
(see Luskin and Shatz,  1985a, b). All neurons undergoing DNA synthesis 
at the time of the injection will incorporate [3H]thymidine, but only those 
that undergo their final round of cell division to become forever postmitotic 
(the cell's birthdate) will be heavily labeled at all subsequent times. There- 
fore, if [3H]thymidine is given at E2"/or E28, and brains are subsequently 
analyzed with autoradiography at later ages, the only heavily labeled neu- 
rons are those of the subplate and marginal zones. 
Subplate neurons were eliminated by exposure to the neurotoxins kainic 
acid (No. K0250; Sigma Chemical Co., St. Louis, MO; Coyle et al., 1978) 
or ibotenic acid (No. I0382;  Sigma Chemical Co.; Schwarcz et al.,  1979; 
see also Jonsson, 1980).  Each toxin was diluted (10 mg/ml) in 0.9 % sterile 
saline and used within 2 h. For animals at E44 and older,  a sterile dental 
drill was used to remove a  portion of the cranium overlying the targeted 
areas in order to insert the injection needle. With the brain surface exposed, 
an array of two to six injections of 0.1  ld were made with a  1-I.tl syringe 
(Unimetrics, Shorewood, IL) at a depth of 1-2 mm in a parasagittal array 
across the cerebral cortex of the right hemisphere. The  .left hemisphere was 
treated identically except that vehicle solution (0.9% sterile saline) was in- 
jected. Animals were then returned to the uterus, developing an additional 
6-16 d  before cesarian section delivery  and tissue preparation.  Table II 
shows the ages at which fetuses were injected and subsequently examined. 
Table II. Experimental  Age of  Neurotoxin Exposure 
and Examination 
Age at  No. of  Neurotoxin*  Age at 
injection  animals  injected  examination 
E40  1  K  E50 
E40*  1  I  E54 
E40w  2  I  E56 
E43  1  I  E51 
E44  1  I  E50 
E45  2  K  E52 
E50w  2  K  E58 
E50  2  K  E58 
E50  2  K  E60 
P4  1  K  P6 
* K, Kainic acid; I, ibotenic  acid. 
* [3H]thymidine  was administered at E27  and tissue autoradiographed at ex- 
amination age. 
w [3H]thymidine was administered  at E40 and tissue autoradiographed  at exam- 
ined age. 
1Issue Preparation for Histology 
Fetuses were anesthetized transplacentally through maternal anesthesia with 
halothane, and postnatal animals were deeply anesthetized with ketamine 
hydrochloride  (20  mg/kg) plus acepromazine  (0.2  mg/kg) delivered  in- 
tramuscularly or subcutaneously, followed by Nembutal (50 mg/kg) injected 
intraperitoneally. Animals were perfused transcardially using a peristaltic 
pump with flow rates varying from 3.5 rnl/min for fetuses to 30 ml/min for 
adult animals. The descending aorta was ligated in animals of length greater 
than 12 cm. Perfusion commenced with Ringer's solution (5 rain, 25~  124 
mM  NaCI,  5  mM  KCI,  1.15 mM KH2PO4,  1.15 mM MgSO4  (7H20), 
2.5 mM CaCI2,  25  mM NaHCO3,  10 mM glucose, pH  7.4;  Shatz and 
Kirkwood,  1984) followed immediately by fresh 4% paraformaldehyde in 
0.1 M monobasic sodium phosphate buffer, pH 7.4 (30 min, 25~  The cra- 
nia were then removed and brains were placed into fresh, circulating fixative 
at 4~  for 12-18 h. Brains were prepared for either cryostat or vibratome 
sectioning. Material to be sectioned by cryostat was removed from fixative 
and placed into a circulating solution of PBS (20 mM monobasic sodium 
phosphate,  150 mM NaCl, pH 7.4) plus 6%  sucrose and 0.025%  sodium 
azide at 4~  for 18-24 h.  Material to be sectioned on the vibratome was 
processed identically except that sucrose was omitted from the buffer. For 
cryostat sectioning, the brain was then frozen by immersion into liquid freon 
(cooled with dry ice), and either sectioned immediately or stored at -60~ 
and sectioned within 48 h. An average of 80 8-10-1xm thick sections were 
cut through the telencephalon in the horizontal  (for  fetuses) or  coronal 
(some fetuses and all postnatal animals) plane, with a particular emphasis 
directed at future visual (or adult visual) cortical areas (lateral and suprasyl- 
vian gyri; see Tusa et al.,  1978). Sections were mounted on subbed slides, 
stored  at  -20~  and processed within 4  h  for  immunohistochemistry 
and/or autoradiography. Material to be vibratome sectioned was embedded 
in 30%  albumin plus 0.5%  gelatin cross-linked with 5%  vol/vol of 50% 
glutaraldehyde and cut at 80 gm (fetal material) or 50 I.tm (postnatal day 
[P] 7 and older) in the horizontal or coronal plane. Sections were stored in 
PBS plus 0.025%  sodium azide at 4~ 
Immunohistochemistry 
Antibodies against the following antigens were used. MAP2 (rabbit anti- 
bovine  polyclonal  diluted  1:2,500  and  mouse  monoclonal  anti-bovine 
MAP2-3 diluted 1:30)  was a  gift from Drs. W.  Theurkauf, E  Luca, and 
R.  Vallee (Worcester Foundation for Experimental Biology, Shrewsbury, 
MA); glial fibrillary acidic protein (GFAP,  rabbit anti-human polyclonal 
diluted 1:500)  was a gift from Dr. L. Eng (Stanford University, Stanford, 
CA).  Antibodies against fibronectins were commercially obtained as fol- 
lows.  Antiserum a:  rabbit  anti-human fibronectin,  No.  341643,  diluted 
1:500;  Calbiochem-Behring Corp.,  La  Jolla,  CA.  Antiserum b"  rabbit 
anti-human fibronectin, No.  A245, diluted 1:2000;  Dakopatts, Copenha- 
gen, Denmark. Antiserum c:  rabbit anti-bovine fibronectin, No.  341632, 
diluted  1:1,000;  Calbiochem-Behring Corp.  In addition,  two monoclonal 
antibodies (showing a qualitatively similar but less intense pattern of stain- 
ing and not characterized using antigen transfer analysis) were used: mouse 
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mouse monoclonal anti-chick cellular fibronectin,  No.  9425SA,  1:500; 
both from Bethesda Research  Laboratories,  Gaithersburg, MD).  Human 
and bovine plasma fibronectin were purchased from Sigma Chemical Co. 
Bound antibody was visualized using Vectastain ABC kits (Vector Laborato- 
ries,  Burlingame,  CA)  and the chromagen 3,3~liaminobenzidine  (DAB; 
grade II, No.  D-5637; Sigma Chemical Co.). 
Sections cut by cryostat or vibratome were processed similarly. Sections 
were first preincubated  at 25~  for 2 h in incubation buffer containing PBS 
plus 2.5% BSA (No. A-4503, fraction V; Sigma Chemical Co.) and 0.3% 
Triton  X-100 (No.  T-6876; Sigma Chemical Co.).  Triton  X-t00  was not 
necessary to observe staining but increased staining intensity. This solution 
was replaced by fresh incubation buffer containing diluted antisera/antibody 
and incubated for 15-24 h at 25~  (free-floating sections  were gently agi- 
tated during incubation).  After incubation, sections  were washed in PBS 
without sodium azide (four changes over 30 min) followed by 60 min in sec- 
ondary antibody (1:200), then washed again (four changes over 30 min), and 
finally  incubated for 40 rain in Advidin Biotin Complex  solution (HRP; 
1:100). The sections were  then washed  (four changes over 30 min) with 
50 mM Tris-buffered saline (50 mM Tris-HCI,  150 mM NaCI, pH Z5) and 
reacted with the addition of 0.5 mg/ml (3,3' Diaminobenzidine) with 0.0075  % 
H202. The sections were then washed again (20 min with two changes of 
TBS).  Vibratome sections were mounted on subbed slides,  air dried, and 
processed along with cryostat sections through three washes of distilled wa- 
ter followed by dehydration in graded ethanols.  All sections were then im- 
mersed in 100% xylene for 8 h, rehydraled,  and dipped in 0.4%  osmium 
tetroxide in distilled water for 30 s to intensify the reaction product and pre- 
vent fading.  The sections  were  then either again dehydrated  and cover 
slipped with Permount (Fisher Scientific Co., Fairlawn,  NJ) or washed in 
three changes of distilled water and air dried. They were then dipped, ex- 
posed, and developed for autoradiography  as previously described (Luskin 
and Shatz,  1985a). 
Antigen Transfer  Analyses 
Fetal (E52) a~  postnatal  (P7, adult) brains prepared for antigen transfer 
analysis  (Western blots) were  first perfused with Ringer's  solution as de- 
scribed above. The entire brain was then rapidly removed from the cranium, 
immediately  immersed  in  boiling sample  buffer  (30  mM  dithiothreitol 
[DTT],  10% wt/vol SDS, 0.1 M Tris-HCl, pH Z5, 50% vol/vol glycerol), 
and homogenized  using a motor-driven, teflon-glass homogenizer at 400 
rpm. Additional animals (E39, E48, P7) were processed  through the Ring- 
er's perfusion step, then further homogenized  in a  Hepes  buffer (4 mM 
Hepes, 2 mM EGTA, 2 mM EDTA, 0.32 M sucrose,  1.0 mM phenylmethyl 
sulfonyl fluoride),  and differentially  centrifuged  to yield a crude synapto- 
some preparation (Huttner et al., 1983). The crude synaptosome pellet was 
solubilized  in boiling sample buffer. Once solubilized,  both preparations 
were  stored  at  -20~  before  electrophoresis.  Another preparation was 
made in which, after perfusion with Ringer's  solution, the brain was re- 
moved and immediately frozen in liquid nitrogen. The frozen brain was split 
in the saggital plane and the entire surface was abraded with a file to a depth 
of approximately  2 mm in an effort to remove the pia.  While still frozen, 
the brain was broken to reveal parts of the choroid plexus,  which were re- 
moved. This pia- and choroid-depleted  brain was then processed  as above. 
Samples containing adult cat plasma fibronectin  were obtained by collect- 
ing cat plasma and diluting it 4:5 with boiling sample buffer. Adult human 
and bovine plasma FN were obtained from Sigma Chemical Co. and solubi- 
lized in sample buffer. Discontinuous SDS-PAGE (Laemmli,  1970) of the 
desired material was carried out in 1.5-ram thick, 9.5-cm long, 4-15 % gra- 
dient slab gels with a 5-cm, 2.75 % stack. After electrophoresis,  the material 
in the gels was either cut out and stained with Coomassie Blue or processed 
for antigen transfer analysis (Towbin et al.,  1979; Bittner et at.,  1980) on 
0.45-~tm nitrocellulose  membrane (Schleicher and Schuell,  Keene,  NH). 
After transfer, the nitrocellulose  was incubated for 8 h at 25~  in TBS plus 
2.5% BSA with 0.025% sodium azide, then incubated in the primary anti- 
body at concentrations one-tenth of those used for immunohistochemistry 
(1:10,000-1:20,000). Blocking controls were conducted by simultaneous  in- 
cubation with native bovine plasma FN (No. F-4759; Sigma Chemical Co,) 
or human plasma FN (No. F-2006;  Sigma Chemical Co.) at 23 nM or 10 
gg/ml. Normal rabbit serum controls were conducted  at twice the concen- 
tration of that used for FN antisera. After a 12-15-h incubation at 25~  the 
bound antibody was visualized  in identical  fashion to immunohistochemi- 
cally visualized  material, except that all washes  made use of TBS,  wash 
times were doubled, and the chromogen 4-chloro-l-napthol (No. C-8890; 
Sigma Chemical Co.) was used in a 0.5 % solution in 17  % methanol, 0.15  % 
H202 in TBS (modified  from Vector Laboratories,  Burlingame,  CA). 
Figure 2. Three different antisera against plasma fibronectins (FNs) 
recognize both adult cat plasma FN (200-220-kD doublet) and a 
molecule  from  plasma-depleted  embryonic  brain  (200-250-kD 
broad  band)  on  antigen transfer analyses  (reducing  conditions). 
Even-numbered lanes contain cat plasma FN, while odd-numbered 
lanes  contain  preparations  of plasma-depleted  (buffer perfused) 
E52 whole brain, a, b, and c correspond to FN antisera a, b, and 
c (see Materials and Methods for details). All lanes were analyzed 
using 4-15 % SDS-PAGE; lanes 1-6 were subjected to electrophore- 
sis at 150 V; lanes 7 and 8 were subjected to electrophoresis at 60 V. 
At 60 V  (d,  using antiserum b),  brain preparations contained an 
FN-immunoreactive broad band ranging between 200 and 250 kD 
(lane 7), a molecular mass higher than plasma FN (lane 8). Lower 
molecular mass products of less staining intensity that appear to be 
proteolytic fragments are also observed (lane 7).  No bands were 
found in controls in which 23 nM FN was added to antiserum, or 
in which antiserum was replaced by normal rabbit serum. No im- 
munoreactivity was observed either at the dye front or in the stack- 
ing gel.  The positions of molecular mass standards are indicated 
(250 kD  is calculated). 
Results 
The results are presented in three parts. First, the specificity 
of the  anti-FN  antisera  is  evaluated  with antigen  transfer 
analyses of plasma and brain preparations.  Next, the histo- 
logical localization of FN-like immunoreactivity in fetal and 
postnatal  brain  is determined using  the  same antisera.  Fi- 
nally, the relationship between FN-like immunostaining and 
the subplatc  neurons  is examined. 
Antigen Transfer  Analyses 
To examine the specificity of the anti-FN antisera used in this 
study, we first characterized antisera a, b, and c (see Fig. 2, 
a, b, and c; see Materials and Methods for identifications) 
using antigen transfer analyses of adult cat plasma FN.  As 
shown in Fig. 2 (lanes 2, 4, and 6) all three antisera recog- 
nize two protein bands (a doublet) with an apparent molecu- 
lar mass around  200-220  kD in a preparation  of adult  cat 
plasma analyzed by 4-15 % gradient SDS-PAGE at 150 V. No 
other major bands  were observed.  The doublet comigrates 
with both human  and bovine plasma FN, is not present on 
transfers exposed to FN antisera  with 23 nM FN incubated 
simultaneously, and cannot be reproduced by normal rabbit 
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eral different ages contain simi- 
lar  FN-like  molecules.  Adult 
plasma  FN  (lane  1),  plasma- 
depleted whole E52 brain (lane 
2),  and plasma-depleted crude 
synaptosome preparations (E48 
in lane 3, E39 in lane 4) were 
analyzed  using 4-15% SDS- 
PAGE at  60 V  (see Materials 
and Methods for further details). 
Preparations  at  all  three  ages 
contain  immunoreactive bands 
of higher molecular mass than 
in plasma (top arrow 250 kD; 
bottom arrow 220 kD). The po- 
sitions of molecular mass mark- 
ers are indicated (250 kD is cal- 
culated). 
serum controls at any dilution (not shown).  The apparent 
molecular  mass  is  identical  to  that  reported  in  previous 
studies of plasma FN (reviewed by Hynes and Yamada,  1982; 
Hynes 1985). 
These same three antisera were used to examine whether 
FN or a  molecule with  similar immunologic and  electro- 
phoretic properties (i.e., an FN-like molecule) is present in 
fetal brain at E52, a time when extensive neuronal migration 
and axonal elongation is occurring in the cat telencephalon 
(Luskin and Shatz, 1985b;  Shatz and Luskin, 1986). Whole 
brain homogenates were prepared first in an effort to include 
all the possible molecules present within brain that show im- 
munologic similarity to FN. The brains were perfused with 
Ringer's  solution before homogenization in order to mini- 
mize contamination of the preparation by FNs in fetal plas- 
ma.  Lanes 1, 3, and 5 of Fig. 2  show that E52 whole fetal 
brain contains a protein, recognized by all three antisera, with 
a molecular mass nearly identical to that of adult plasma FN 
when subjected to electrophoresis at 150 V. When the elec- 
trophoretic voltage is decreased (Fig.  2  d;  60 V), the im- 
munoreactive material in the E52 brain sample migrates as 
a broad band with an upper limit molecular mass of '~250 
kD (lane 7), always higher than plasma FN under identical 
conditions (lane 8).  This higher molecular mass  material 
was not eliminated in pia- and choroid plexus-depleted brain 
(not shown;  see Materials  and Methods).  We did not ob- 
serve any other bands of similar intensity in the gel or in 
the stack. The immunoreactive broad band was not present 
when 23 nM FN was added in blocking controls, or in nor- 
mal rabbit serum controls (not shown). A consistent finding 
was the presence of FN-immunoreactive products of molecu- 
lar mass <200 kD (see lane 7), although these products were 
always  of lesser intensity compared with the broad band. 
While all three FN antisera behaved in similar fashion, the 
rabbit anti-human FN antiserum b appeared most sensitive 
and it was therefore  used more extensively for subsequent an- 
tigen transfer analyses. 
A  slightly  modified approach  was  to  examine  plasma- 
depleted (perfused) crude synaptosome preparations for FN- 
like molecules as compared with plasma and whole brain ho- 
mogenate preparations in order to gain further insight into 
the subcellular distribution of FN-like immunostaining. In 
Fig. 3, lane I  contains a preparation from adult plasma and 
lane 2 from E52 whole brain, while lanes 3 and 4 are from 
synaptosome preparations at ages E48 and E39, respectively 
(subjected to electrophoresis at 60 V). The 200-220-kD ap- 
parent molecular mass of adult plasma FN in lane I contrasts 
with the 200-250 kD broad bands of lanes 2-4. These anti- 
gen transfer results combined with those in Fig. 2 show that 
each of three anti-FN antisera recognizes not only an adult 
plasma molecule with the same 200-220-kD molecular mass 
doublet reported for plasma  FNs,  but also a  200-250-kD 
broad band  from plasma-depleted whole fetal brain  (both 
forms  of FN  are  reviewed in  Hynes and  Yamada,  1982; 
Hynes, 1985). Similar forms are also present in E48 and E39 
plasma-depleted synaptosome preparations. 
Distribution of  FN-like Immunoreactivity 
The same three antisera used in the antigen transfer analyses 
(antisera a, b, and c in Fig. 2) were next applied to cryostat 
sections of brain to examine the distribution of FN-like im- 
munostaining within E50 brain. At this age, as shown in the 
cresyl violet-stained section of Fig. 4 d, the telencephalon 
can be subdivided histologically into the several embryonic 
layers  identified  in  Fig.  1.  When  adjacent  sections  were 
stained with antisera a, b, or c, the same general pattern of 
staining was observed in each case (Fig. 4, a-c; panel letters 
correspond  to  antisera).  The  FN-like  immunostaining  is 
present in the marginal zone and the subplate region of the 
intermediate zone (cf. Fig. 4, a-c and d), but is absent from 
the cortical plate and ventricular zone. It is also present, al- 
though with less intensity, in the lower part of the intermedi- 
ate zone. The pia mater (Fig. 4 a, Pia) as well as the choroid 
plexus (Fig. 4 a, Chr) are also immunostained. Normal rab- 
bit serum controls did not reproduce this  staining pattern 
(Fig. 4 e) and staining also could be blocked completely for 
all three antisera by the addition of 23  nM  FN incubated 
simultaneously with antisera (shown in Fig. 4ffor antiserum 
b). Since all three antisera always showed the same staining 
patterns  with  respect to each other at  every age  studied, 
results obtained using antiserum b will be presented in the 
subsequent figures. 
While FN-like immunostaining in the fetal brain is con- 
centrated in the subplate, the immunohistochemical pattern 
in the adult is completely different, with no staining in the 
white matter. Fig. 5 a shows the adult pattern of anti-FN im- 
munostaining observed by P70 and complemented by two 
older ages, P178 (Fig.  5 b) and >l-y-old (Fig.  5 c). Fig. 5, 
a-c shows  that FN-like immunostaining is absent from the 
white matter. The controls shown in Fig. 5, d-f indicate that 
the staining of the cortex and other areas of adult neuropil 
in Fig. 5, a-c is nonspecific (Fig. 5, d and e are FN-blocking 
controls; Fig. 5fis a normal rabbit serum control). We have 
previously observed nonspecific staining in areas of high cell 
density using other non-FN antisera on vibratome cut sec- 
tions and this phenomenon has been previously reported for 
similarly prepared adult brain  (Hendry et al.,  1984).  The 
nonspecific staining does serve to clearly demarcate the cor- 
tical layers from the unstained white matter.  Since, in our 
experience, vibratome sections provided greater sensitivity 
at  fetal ages  than  cryostat sections  for detecting  FN-like 
immunoreactivity, vibratome sections were preferred over 
Chun and Shatz  Fibronectin in Cerebral Cortical Development  861 Figure 4. The three anti-FN antisera (a-c) show identical patterns of tissue immunostaining at E50. Adjacent 8-1xm  thick coronal sections 
through the telencephalon in the region of future visual cortex at E50 were stained with the same three antisera analyzed in Fig. 2. Fig. 
4 d is an adjacent cresyl violet-stained section to illustrate the histological organization of the telencephalon at this age (see also Fig. 1). 
(e) A control using normal rabbit serum; (f) a blocking control in which 23 nM FN was added. The pia (P/a or leptomeninges) and 
choroid plexus (Chr) are immunostained. Immunostaining is also present in the marginal zone (MZ) (cf. d) and the subplate (SP), but 
not in the lower part of the intermediate zone (/Z) or in the ventricular zone (F-Z). Note the clear absence of immunostaining from the 
cortical plate (CP). Orientation of sections is given in d: D, dorsal; L, lateral; M, medial; 1I, ventral. 
those cut by cryostat for postnatal and adult ages. (Cryostat 
sections at all ages showed qualitatively identical results). In 
addition to the absence of white matter staining, note that 
blood vessels are also unstained for FN in the cerebral cortex 
of adult animals (Fig. 5, a-c). We have never observed any 
adult cerebral cortical blood vessel FN-like immunostaining 
by the three antisera used in this study in either vibratome- 
or cryostat-sectioned material. 
The presence of FN-like immunostaining at E50 and its 
absence in the adult suggest that this immunostaining is tran- 
sient. To examine the time course of disappearance of FN- 
like immunostaining, a developmental series was prepared. 
Fig. 6 a  is a cresyl violet-stained section and can be com- 
pared with Fig. 6 b, which shows that by E46, the earliest 
age examined histologically, the subplate and marginal zones 
are already immunostained. FN-like immunostaining of the 
subplate is maintained through E52 (Fig. 6 c) and E60 (Fig. 
6 d), although marginal zone immunostaining is not detected 
after late E50 to early E60 (only the pia mater shows su- 
perficial staining at these later ages). As the subplate gradu- 
ally matures to become the white matter, immunostaining in 
this zone declines, as can be seen by P7 (Fig. 6f). The disap- 
pearance of subplate/white matter staining is uneven, result- 
ing in the persistence of islands of FN immunostaining at the 
bases of the cortical gyri (cf. Fig. 6fwith Fig, 6 g; in g, the 
most dorsal island is enclosed in a box). These islands of FN- 
like immunostaining have vanished by P49 (Fig. 6 h), when 
only a faint rim of staining separates layer 6 from underlying 
white matter (Fig. 6 h, arrows). By P28, the previously noted 
nonspecific background staining increases, thereby making 
it difficult to identify unequivocally specific immunostaining 
in some brain regions such as the thalamus (asterisks in Fig. 
6, g and h). However, control experiments at P28 and P49 
indicate that the FN-like immunostaining within the white 
matter is specific. 
In addition to the cerebral cortex, FN-like immunostaining 
is observed developmentally within the cell-poor regions of 
the hippocampus (H in Fig. 6, a, d, and e, compared with 
b and c), the thalamus (L indicates the lateral geniculate nu- 
cleus of the thalamus in Fig. 6, a  and e, compared with b, 
c, and f), and the midbrain (MB in Fig. 6 d). Like the neo- 
cortex, regions of high cell density are devoid of FN-like im- 
munostaining. Thus, Fig. 6 shows that by E46, FN-like im- 
munostaining  is  present  within  cell-poor  regions  of the 
The Journal of Cell Biology, Volume  106, t988  862 Figure 5. FN immunostaining is not present in the white matter (WM) of  adult animals nor by P70. In these 50-p.m thick vibratome sections 
cut in the coronal plane through visual cortex, immunostaining (a-c) of cortex (Ctx), hippocampus (H), and thalamus (not labeled) is 
not specific since it is also present in FN blocking controls of matched sections (cf. d and a; e and b), and in normal rabbit serum controls 
(cf. fand c; see text for further details). Note the absence of blood vessel staining in these sections, which are all prepared from buffer- 
perfused brains. Orientation is identical to that shown in Fig. 4 d. 
brain, particularly in the subplate and marginal zones and is 
absent from cell-dense regions  such  as  the cortical plate. 
This pattern persists into the early postnatal period,  after 
which  immunostaining  first clears  from the  white matter 
near sulci, leaving islands at the bases of the gyri. By P49 
most of  the islands have also disappeared so that by P70 (Fig. 
5) no FN-like immunostaining can be detected in the white 
matter. 
Correlation  between FN-like lmmunostaining 
and Subplate Neurons 
These observations raise the issue of what cellular element 
or elements might be responsible for producing the FN-like 
immunostaining seen in the subplate and marginal zones of 
the developing cerebral cortex. In analyzing the distribution 
of FN-like immunoreactivity, we were struck by the similar- 
ity in location and time course of disappearance between the 
FN-like immunostaining in the subplate and marginal zones, 
and the subplate and marginal zone neurons. For example, 
Fig. 7 a  is a cresyl violet-stained cryostat section showing 
selected embryonic zones. Fig. 7, b and c are micrographs 
of the same field from a section adjacent to 7 a,  immuno- 
stained for FN;  Fig.  7  b  shows  the section observed with 
darkfield optics (immunostaining appears white) and Fig. 7 
c is the same section in brightfield optics (immunostaining 
appears black). As indicated in Fig. 7, a and b, the subplate 
can be divided into an upper (SPy) and lower (SPL) part, 
both of which contain the early generated subplate neurons 
as identified by [3H]thymidine autoradiography. The higher 
packing density of cell somata, however, distinguishes the 
more compact upper subplate from the less dense lower sub- 
plate. In Fig. 7 b, the position of the upper subplate can be 
accurately determined by noting the clusters of silver grains 
over the nuclei of the subplate neurons (note arrows) that 
were  [3H]thymidine  labeled  at  E27  (Luskin  and  Shatz, 
1985) and subsequently examined here at E56 with a combi- 
nation ofFN immunohistochemistry followed by autoradiog- 
raphy. Comparison with Fig. 7 c illustrates that the relatively 
cell-poor lower subplate contains extensive FN-like immu- 
nostaining.  Conversely, FN-like immunostaining does not 
Chun and Shatz Fibronectin in Cerebral Cortical Development  863 Figure 6.  FN immunostaining is present prenatally in the subplate (SP) and diminishes postnatally in the white matter (WM). Specific 
immunostaining fills the subplate at E46, E52, and E60 (b-d), and white matter at P7 (f). At P28 (g) and P49 (h), immunostaining begins 
to decrease in the white matter, a and e are cresyl violet-stained  sections adjacent to those ofb and d, to show the histological organization 
of the brain at F_A6 (a and b) and P7 (e and f). Immunostaining is also present in the marginal zone at EA6 and E52, but cannot be detected 
there by E60 (d). Cell poor regions of the thalamus such as those surrounding  the lateral geniculate nucleus (L in a  and e) and of the 
hippocampus (H) are also immunostained between E46 and P7. However, by P28 nonspecific immunostaining (asterisks in g and h) in- 
creases, making specific immunostaining difficult to detect. All sections are cut coronally except those in a and b, which are horizontal 
sections. Orientation of a and b is given in a: L, lateral; M, medial; A, anterior;  P, posterior.  All other sections are oriented as shown 
in c: D, dorsal; V, ventral. Identified neuroanatomic structures: marginal zone (MZ), layer 1 (1), cortical plate (CP), cortex (Ctx), subplate 
(SP), ventricular zone (VZ), caudate (C), hippocampus (H), lateral geniculate nucleus (L), midbrain (MB), and choroid plexus (Chr). 
Rectangle in g encloses an island of FN-like immunostaining shown at higher magnification in a. Arrows in h indicate residual FN-like 
immunostaining at the cortex-white  matter border. Bars: (a-d) 3 mm; (e-h) 5 ram. 
appear to invade substantially the cell-rich upper subplate. 
Thus, as shown in Fig. 7, b and c, the heaviest FN-like immu- 
nostaining is present in the lower subplate, and this staining 
declines near the base of the upper subplate. 
To examine further the correlation between FN-like im- 
munostaining  and  the  position of subplate  neurons  in  the 
lower  subplate,  thicker  (80-1xm  vibratome)  sections  were 
stained with FN antisera to obtain more complete informa- 
tion on subplate neuron morphology. As shown in Fig. 8 a, 
the typical appearance of subplate neurons at E50 can be re- 
vealed clearly by  immunostaining them with  an antibody 
against MAP2.  Many have pyramidal shaped somata (large 
arrows) with one or more dendrites directed into the lower 
subplate and towards the ventricular zone (curved arrows). 
Cells with remarkably similar morphologies are also FN- 
immunostained, as shown in Fig. 8 b (large arrows). In addi- 
tion, a blood vessel is immunostained (asterisks in Fig. 8, b, 
c', and c") along with more diffuse subplate labeling. At least 
some of the FN-like immunostained somata such as those 
shown  in  Fig.  8  b  are  subplate neurons  as  confirmed by 
[3H]thymidine birthdating of subplate neurons at E27,  fol- 
lowed by immunostaining at E50.  The result of this experi- 
ment,  shown  in  Fig.  8,  c  and c" demonstrates that  some 
FN-immunoreactive cells can also be labeled with [3H]thy- 
midine,  thus identifying them as subplate neurons. 
The time course and pattern of disappearance of FN-like 
immunostaining is also correlated with that of the subplate 
neurons. As the subplate neurons gradually disappear from 
the white matter during early postnatal life, so too does FN- 
like immunostaining, leaving islands of stain such as those 
observed at P28 (Fig.  6 g, boxed area). Fig. 9  a  shows an 
enlarged photo of the island of FN-like immunostaining en- 
closed by the box in Fig. 6 g. The dark, diffuse, FN-like im- 
munostaining within the white matter of Fig.  9 a  contrasts 
with the white, unstained region of neocortex. When an adja- 
cent section (Fig. 9 b) was immunostained with MAP2 to re- 
veal the location of the subplate neurons,  MAP2-immuno- 
reactive cells were also found in similar locations within the 
islands. (It should be noted that at this postnatal age, MAP2 
also stains the neurons of the cerebral cortex). Proof that the 
MAP2-immunoreactive cells are indeed subplate neurons is 
provided in Fig. 9 c, a higher magnification of the boxed area 
in Fig.  9  b.  In this experiment,  a  [3H]thymidine injection 
was  made  at  E27  to  label  some of the  subplate  neurons, 
The Journal of Cell Biology, Volume  106, 1988  864 Figure 7. FN-like immunostaining at E56 is located primarily within the lower subplate. (a) A cresyl violet (CV)-stained cryostat section 
showing the histological subdivision between the lower (SPL) and upper (SPy) parts of the subplate. (b) A darkfield photomicrograph of 
an adjacent cryostat section immunostained for FN and then prepared for autoradiography to reveal [3H]thymidine-labeled  neurons of the 
SPu that had been birthdated at E27. Note that the neurons of the upper subplate (white arrows indicate silver grains over nuclei) sit just 
above the region of  the most dense FN-like immunostaining. (c) A brightfield photomicrograph of  the same section as in b. Note that FN-like 
immunoreactivity also labels a blood vessel (/arge arrow in b and c). All sections are oriented with pial surface to the top of the page. 
which were subsequently examined at P28 by both MAP2 
immunostaining and autoradiography. The curved arrows in 
Fig. 9 c mark MAP2-immunostained cells with silver grains 
over their nuclei, thereby identifying them as subplate neu- 
rons.  Thus,  FN-like  immunostaining  not  only  correlates 
with the presence of subplate neurons during fetal life, (the 
lower subplate neurons in particular) but also with the time 
course and pattern of their disappearance during early post- 
natal life. 
To learn more about the correlation between FN-like im- 
munoreactivity and subplate neurons, subplate neurons were 
partially eliminated to examine the effect of this perturbation 
on the distribution of FN-like immunoreactivity. Subplate 
neurons were killed during fetal life by making injections of 
the excitatory neurotoxins kainic acid (Coyle et al.,  1978) or 
ibotenic acid (Schwarcz et al., 1979) at E40, E43, or E45 and 
then examining the consequences 1-3 wk later (see Table II 
for exact ages).  The effectiveness of neurotoxin treatment 
was evaluated by using anti-MAP2 to detect remaining sub- 
plate neurons. Both neurotoxins destroyed subplate neurons, 
although kainic acid injection produced a larger, less local- 
ized lesion than that from ibotenic acid.  Fig.  10 shows the 
results of an experiment in which kainic acid was injected at 
E45 and the brains  were examined at E52.  A  cresyl vio- 
let-stained section (in Fig.  10 a) reveals that the subplate is 
markedly hypercellular (Fig. 10 a; subplate borders are indi- 
cated by arrows) as compared with the control hemisphere 
(Fig.  10 e).  An  adjacent section from the lesioned hemi- 
sphere stained with anti-MAP2 (Fig.  10 b) shows  markedly 
decreased staining  compared with the control hemisphere 
(Fig.  10 f), indicating that, except for a rim of cells at the 
cortical plate-subplate border, the majority of subplate neu- 
rons were eliminated. Confirmation that the loss of MAP2 
immunostaining reflected subplate neuron deletion was es- 
tablished  by  another  experiment  (not  shown)  in  which 
[3H]thymidine-labeled subplate  neurons  were  also  elimi- 
nated from neurotoxin lesioned, MAP2-depleted areas. 
Adjacent sections stained with anti-FN revealed that FN- 
like immunostaining in the lesioned region is also markedly 
decreased (Fig.  10 c) as compared with the control hemi- 
sphere (Fig.  10 g). Paralleling the rim of surviving subplate 
neurons labeled by MAP2 (Fig.  10 b), a rim of FN-like im- 
munostaining remained at the cortical plate-subplate border 
(Fig.  10 c). Note that despite the elimination of FN-like im- 
Chun and Shatz Fibronectin  in  Cerebral  Cortical  Development  865 Figure 8, Subplate neurons are delineated by FN-like immunostaining. The subplate neurons have characteristic morphologies, as revealed 
with MAP2 immunohistochemistry. (a) A photomicrograph of the lower subplate from an E50 brain immunostained for MAP2. Large 
arrows indicate several somata; curved arrows indicate the often beaded dendritic processes. When similar tissue is immunostained for 
FN, morphologically similar cells can be observed (/arge and curved  arrows as in a); a large blood vessel (asterisk) is also FN immunoreac- 
tive. (c-c") Some of the FN immunostained cells are subplate neurons, since they can also be labeled by [3H]thymidine  administered on 
their birthdate at E27. In c and c", the arrow points to silver grains over subplate neuron nuclei; c' is at a different focal plane from the 
same cell shown in c" (asterisks indicate a labeled blood vessel). Orientation of all photos is with pial surface towards the top of the page. 
munostaining from the subplate, blood vessel immunostain- 
ing is still present within the lesioned region (Fig.  10 c). To 
assess whether the treatment was selective for SP neurons or 
whether  glia  were also  eliminated,  an  antiserum  against 
GFAP (found in radial glia and astrocytes; Eng et al.,  1971; 
Bignami and Dahl,  1974) was also applied to adjacent sec- 
tions. In the lesioned hemisphere (Fig.  10 d), GFAP immu- 
nostaining appeared increased compared with its low levels 
in the control hemisphere, indicating that GFAP-positive glia 
are still present, Thus, after neurotoxin elimination of sub- 
plate neurons, FN-like immunostaining decreases within the 
subplate in a similar regional pattern. This result is consis- 
tent with the temporal and spatial correlation between FN- 
like immunostaining and the subplate neurons drawn earlier 
(see above). 
Discussion 
In this study, antigen transfer analyses using antisera raised 
against FNs show that a molecule (or complex of molecules) 
with an apparent molecular mass of 200-250 kD is present 
within fetal cat brain. The molecule has immunologic and 
electrophoretic similarities to FNs, cellular FNs in particu- 
lar. These same antisera used immunohistochemically rec- 
ognize not only fetal blood vessels, pia mater (leptomenin- 
ges), and choroid plexus, but also stain the neuropil of the 
subplate and marginal zones within the developing cerebral 
cortex. As  the cortex matures,  FN-like immunoreactivity 
gradually disappears from the marginal zone (by late prena- 
tal life) and subplate (postnatally) so that by P70 no specific 
immunostaining remains in the white matter (the adult pat- 
tern). Moreover, the presence and subsequent disappearance 
of FN-like immunoreactivity is spatially and temporally cor- 
related with the presence and disappearance of the subplate 
neurons, both in normal development and when the subplate 
neurons are artificially removed by neurotoxin injections, 
suggesting that the subplate neurons play an important role 
in the regulation and expression of FNs. 
Identity of  the In Situ Molecule(s) 
The interpretation of the results rests on both the specificity 
of the antisera used, and on the identification of the mole- 
cule(s) whose recognized determinants are responsible for 
the staining patterns observed in situ. The specificity of the 
three antisera used in this study is validated by the ability of 
each to (a) recognize adult cat plasma FN on antigen-transfer 
analyses; (b) recognize known FN-positive compartments, 
i.e., growing blood vessels, the pia mater, and the choroid 
plexus (Schachner et al.,  1978; Pateau et al.,  1980a;  Minier 
et al.,  1981; Hatten et al.,  1982; Jones et al.,  1982; Hynes 
et al.,  1986);  and  (c)  show  susceptibility to blocking by 
23 nM (10 gg/ml) of FN on antigen transfers and in tissue 
sections. In addition, the nearly identical immunostaining 
patterns amongst all three antisera on transfers and in tissue 
sections are consistent with the interpretation that each an- 
tisera is recognizing the same antigen, i.e., FN, the antigen 
against which each antiserum was raised. However, we can- 
not be absolutely certain of the identity of the recognized 
antigen in the subplate without both eDNA in situ hybridiza- 
The Journal of Cell Biology,  Volume 106,  1988  866 Figure 9.  Subplate neurons coincide postnatally with islands of FN-like immunostaining. (a) An enlargement of the FN-immunostained 
region enclosed  in the rectangle of Fig.  6 g at P28. (b) An adjacent section (cf. arrows pointing to same blood vessel) immunostained 
with MAP2 to show that many subplate neurons are still present in this part of  the maturing white matter. (Note that at this age, the neurons 
of  the cerebral cortex are also MAP2 inmaunoreactive). That these MAP2-1abeled cells are subplate neurons can be shown by autoradiogra- 
phy after prior [3H]thymidine administration at their birthdate on E27. The area enclosed by the rectangle in b is enlarged in c (asterisk 
in upper right corner) to reveal the presence of autoradiographicaUy labeled subplate neurons (curved arrows; note silver grains over their 
nuclei). 
tion and specific FN mRNA evidence. Because of this uncer- 
tainty,  we  have  retained  the  term  FN-like  to  refer to  the 
results shown on blots and in tissue sections. In the following 
discussion (below) the term FN (instead of FN-like) will be 
used, but the true identity of the observed molecule(s) awaits 
further study. 
A variety of observations suggest that the antisera recog- 
nizes a cellular form of FNs in fetal cat brain. Cell surface 
FNs are known to have a higher molecular mass than plasma 
FN  (Hynes,  1976; Yamada and Kennedy,  1979; Hynes and 
Yamada, 1982;  Hynes, 1985),  to show cross-reactivity with 
antisera  against  plasma  FN  (Ruoslahti  and  Vaheri,  1974; 
Hynes and Yamada, 1982),  and to exhibit varied migration 
depending on electrophoretic conditions (Hynes,  1976; Ya- 
mada and Kennedy, 1979), all of which were observed in the 
present study. The existence of the 200-250-kD broad band 
is also consistent with the known heterogeneity of cellular 
FN subunits that arise through variations in posttranscrip- 
tional  mRNA  splicing  and/or  differences in  glycosylation 
(Paul et al.,  1986). 
Several cellular compartments within brain probably con- 
tribute to the broad band observed in antigen transfer analy- 
ses. While we cannot exclude the possibility that the entire 
broad band is due only to the blood vessels, pia mater, and 
choroid plexus, such an interpretation does not take into ac- 
count our findings that (a) a  similar band is recognized in 
synaptosome preparations  from  which  these  cellular  ele- 
ments have been at least partially eliminated,  and  (b) the 
subplate and  marginal zones are  immunostained  in  tissue 
sections.  Thus,  several  cellular  compartments within  the 
developing brain probably contain FNs, a suggestion consis- 
tent with the observation that depletion of FN immunostain- 
ing in the subplate by means of neurotoxins leaves the blood 
vessel staining  intact.  We cannot determine whether each 
compartment contributes a separate component to the 200- 
250-kD broad band, or whether instead the same heteroge- 
neous molecular form is made by all cellular elements. Evi- 
dence favoring the possibility that the forms associated with 
each cellular element differ comes from studies of cultured 
endothelial cells that appear to synthesize FNs with molecu- 
lar masses of <250 kD (Jaffe and Mosher,  1978; Macarak et 
al.,  1978; Birdwell et al.,  1978; Sage et al.,  1979; Vlodavsky 
Chun and Shatz Fibronectin in Cerebral Cortical Development  867 Figure 10. The elimination  of subplate  neurons is correlated with a decrease in FN-like immunostaining.  At E45,  neocortical injections 
of the neurotoxin  kainic acid were made into one hemisphere to delete subplate  neurons (a-d); vehicle solution  (0.9%  sterile saline) was 
injected in the other hemisphere (e-h). The consequences of the injections  were examined at E52.  Adjacent coronal sections were stained 
with cresyl violet (OF), or with antibodies  against FN, MAP2, or GFAP. In cresyl violet-stained sections,  the marginal  zone (MZ) and 
cortical  plate (CP) appear essentially  normal, but there is an increase  in cell density within the subplate (SP) and intermediate  zone (/Z) 
on the lesioned  side (cf.  a  and e).  Within the lesioned  hemisphere, MAP2 immunostaining  is greatly reduced (cf. b and f), indicating 
a loss of subplate neurons. Adjacent sections (within 400 ~tm) show that while blood vessel staining is present in both hemispheres,  FN-like 
immunostaining  of the subplate is drastically reduced on the side of the neurotoxin lesion (c). At the same time, immunostaining  for GFAP 
is increased in the lesioned hemisphere (cf. d and h). Orientation  of  each section is with pial surface towards the top of  the page as indicated 
in e: D, dorsal; M, medial;  V, ventral; and L, lateral. 
et al., 1979). Whatever the case, the fact that all three antisera 
recognize one  broad band  in  antigen  transfer  analyses  of 
whole  brain  preparations  argues  that  the  immunostaining 
seen in tissue sections is due to FN rather than to the pres- 
ence of different molecules sharing the same determinants. 
Thus, our results suggest that a molecule similar or identical 
to  FN  is  present  in  the  fetal  cat telencephalon  and  is  as- 
sociated not only with plasma, blood vessels, pia mater, and 
choroid plexus  but also with elements  of the  subplate  and 
marginal zones. 
Comparisons with Previous Studies 
FN immunoreactivity has been reported in the subplate and 
marginal zone of the developing fetal mouse cerebral cortex 
(Stewart and Pearlman,  1987) and in one study of the mouse 
cerebellum (Hatten et al.,  1982; but see Hynes et al.,  1986). 
While our own results cannot address the discrepancy that 
exists between the two studies on cerebellum, they are con- 
sistent with the'recent study of mouse cerebral cortex.  It is 
noteworthy that mouse cortical immunostaining can only be 
detected for a brief 7-d period, whereas in the cat, it is pres- 
ent for over 2 mo. This difference underscores the point that 
the failure  to find FN immunostaining  in a  species  with a 
rapid developmental time table may be due to its very brief 
expression. While we did not look for FNs in cat cerebellum, 
we did find thalamic and midbrain  immunostaining in this 
study, suggesting that the presence of FNs in the central ner- 
vous system is a  more generalized phenomenon, at least in 
cat. 
Our finding that FN immunoreactivity is present in the de- 
veloping central nervous system is not in agreement with the 
results  of most other previous studies.  However,  there  are 
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First, some studies did not concentrate on the developing 
neocortex, instead examining other central nervous system 
regions (Schachner et al., 1978; Minier et al., 1981; Jones et 
al., 1982; Hynes et al., 1986). Second, as mentioned above, 
many of the reports studied animals in which the pace of de- 
velopment is considerably faster than that in the cat (Schach- 
ner et al., 1978; Minier et al., 1981; Hynes et al., 1986), mak- 
ing the detection of developmentally relevant FN critically 
dependent on choosing the appropriate age, as well as the ap- 
propriate location. Further, significant differences exist in 
the histological techniques used in our study and those used 
previously, such as fixation, tissue processing, and immuno- 
histochemistry, and the period of primary antiserum incuba- 
tion,  which in our study was 48-72  times longer than in 
others (Schachner et al., 1978; Minier et al.,  1981; Jones et 
al., 1982). We can demonstrate FN immunostaining in vibra- 
tome and cryostat sections, with or without Triton X-100 (but 
more robust staining was found in vibratome sections with 
Triton), suggesting that one of the more important variables 
is probably the period of primary antisera incubation rather 
than tissue preparation. 
It is also remarkable that we did not find blood vessels im- 
munoreactive for FN in the adult cerebral cortex, in contrast 
to previous reports (Stenman and Vaheri, 1978; Schachner et 
al., 1978; Pateau et al., 1980a; Minier et al., 1981; Jones et 
al., 1982). This is unlikely to reflect overfixation, since fetal 
blood vessel staining is present in identically prepared tissue. 
The discrepancy may again be explained by methodological 
differences:  most previous  studies did  not use  an  initial 
buffer perfusion to remove plasma FN from within blood 
vessels. Others examined brain tissue that may have under- 
gone pathologic changes, prompting the neurosurgical resec- 
tion from which it was obtained (Pateau et al.,  1980a);  in- 
jured blood vessels can respond by producing FN (Clark et 
al., 1982; Grinnel, 1984). Thus, we suggest that in the cat, 
blood vessels of the developing cerebral cortex do produce 
FNs, while the normal adult endothelium of  the cerebral cor- 
tex does not produce FN or produces it at levels below im- 
munohistochemical detection. 
What Cellular Components Synthesize FN? 
A major finding of this study is that the subplate neurons are 
correlated temporally and spatially with the presence of FN 
immunoreactivity. The results in Fig. 7 suggest that the lower 
subplate neurons may be more closely associated with FN 
than those of the upper subplate, since the greatest FN stain- 
ing is located in the lower subplate.  This implies that FN- 
mediated development involves the participation of only part 
of the subplate neuron population. Such population hetero- 
geneity has previously been indicated by the different neu- 
ropeptide immunoreactivities of the upper vs.  lower sub- 
plate neurons (somatostatin vs. neuropeptide Y respectively; 
Chun et al., 1987). However, both upper and lower subplate 
neurons appear to direct many of their cell processes (proba- 
bly dendrites) into the lower subplate (Figs. 8 and 10) so that 
it is possible that not only the lower subplate neurons but also 
those of the upper subplate are associated closely with FN. 
The loss of FN immunoreactivity after elimination of sub- 
plate neurons raises the possibility that the subplate neurons 
themselves may be one source of FN. However, until it can 
be proven that subplate cells synthesize FN, one must con- 
sider the many other potential sources for FN production, in- 
cluding plasma (Mosesson and Umfleet, 1970; reviewed by 
Hynes and Yamada,  1982), CSF (Kuusela et al.,  1978), the 
choroid plexus, leptomeninges and blood vessels, astrocytes 
(Kavinsky and Garber,  1979; Price and Hynes,  1985; but 
contrast with Raft et al., 1979; Kennedy et al., 1980; Pateau 
et al., 1980b; Stieg et al., 1980; Jones et al., 1982), and mac- 
rophages  (reviewed by Hynes,  1981; Hynes and Yamada, 
1982). We note simply that while each of the cellular ele- 
ments listed above certainly could synthesize the observed 
FN molecule and supply it to the subplate and marginal 
zones, none appears to show as strong a temporal and spatial 
correlation with FN immunostaining as do the subplate neu- 
rons themselves. 
Another possibility is that subplate (and marginal zone) 
neurons could regulate, if not synthesize, FNs by interacting 
with FN-synthesizing cells such as glia. This is perhaps a 
more reasonable alternative, since there are no known exam- 
ples  indicating that neurons can  synthesize FNs.  For in- 
stance, the elimination of subplate neurons by the neurotoxin 
injections might alter glial expression of FNs. It is unlikely 
that neurotoxins eliminate the glia or macrophages, since in- 
spection of the lesion sites indicate that in fact many macro- 
phage-like cells have invaded the area, and GFAP immuno- 
staining shows that the radial glial cells are also still present. 
These observations are consistent with previous studies indi- 
cating that glia are not eliminated by exposure to these neu- 
rotoxins, though they can become "reactive" in response to 
neuronal destruction (Coyle et al., 1981). Thus, it may be that 
when subplate neurons are eliminated by neurotoxin treat- 
ments, the cellular interactions required for FN expression 
are interrupted and FN levels in the subplate fall. 
Possible Roles of  FN in Cerebral Cortical Development 
The results of this study show that FNs or similar molecules 
are present in the subplate and marginal zones, but are not 
detectable within the cortical plate. This differential distribu- 
tion must be considered in thinking about the roles that such 
molecules might play during the development of the cerebral 
cortex.  Of the possible roles for this extracellular matrix 
component, FNs may act to promote cell migration and/or 
neurite elongation, functions they are known to subserve in 
other systems (Hynes and Yamada,  1982; Hatten et al., 1982; 
Rogers et al., 1983; Hynes 1985; Thiery and Duband, 1986). 
The studies of Rakic (1972, 1977) have shown that neurons 
generated at the ventricular surface must migrate long dis- 
tances to take up their positions within the cortical plate. 
Moreover, during development, many axonal projection sys- 
tems must grow to or from the cerebral cortex (thalamocorti- 
cal: Anker and Cragg, 1974; Rakic, 1977; Lurid and Mustari, 
1977; Wise and Jones,  1978; Crandall and Caviness,  1984; 
Shatz and Luskin, 1986; corticothalamic: Shatz and Rakic, 
1981; callosal: Wise and Jones, 1978; Innocenti, 1981; mon- 
aminergic: Lidov et al., 1978). Our results indicate that FNs 
are  certainly  found in  zones  where  these  developmental 
events occur,  namely the subplate and marginal zones.  It 
must be noted, however, that both cell migration and axon 
elongation also occur within the cortical plate. Thus, FNs 
need not mediate these interactions within the cortical plate 
itself. 
The location of FNs are nevertheless appropriate to medi- 
ate cell migration and/or axon elongation within the subplate 
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dence demonstrating that FNs mediate these functions in the 
telencephalon. However, when we decreased FN levels in the 
subplate by making kainic acid lesions, a  hypercellularity 
resulted (see Fig.  10 a). This increase in cell density could 
be due to the fact that the region has been invaded by glia 
in response to damage caused by the lesion (Coyle et al., 
1978;  Murabe  et  al.,  1981). Another explanation for  the 
hypercellularity, which does not exclude the first, is that cells 
normally migrating to the cortical plate cannot traverse the 
lesioned area because FN levels have been decreased. Pre- 
liminary counts of spindle-like cells thought to be migrating 
neurons have revealed a twofold increase in number (lesion 
vs. control) and this could indicate that cell migration within 
the subplate may be,  in part, FN-mediated. 
We have so far considered cellular interactions common to 
both the cortical plate and the subplate and have suggested 
that FNs may subserve these interactions in one area but not 
in the other. Another possibility is that FNs function in inter- 
actions restricted and unique to the subplate.  As mentioned 
in the introduction, the subplate is not only a zone through 
which cells migrate and axons grow, but is also a complex 
synaptic neuropil at a time when the cortical plate is still in 
the early stages of differentiation. Elements that participate 
in this neuropil include the subplate neurons, known to re- 
ceive synaptic contacts, (Chun et al.,  1987) and the ingrow- 
ing axonal systems, known to wait for several weeks before 
invading the cortical plate (Rakic,  1977; Lund and Mustari, 
1977; Wise and Jones,  1978; Innocenti, 1981; Crandall and 
Caviness, 1984; Shatz and Luskin, 1986). These considera- 
tions raise the possibility that axons prefer to remain within 
the FN-rich, cell-poor subplate,  and it is only when FN lev- 
els begin to fall that the extracellular milieu of the cell-dense 
cortical plate becomes more preferable for axon elongation. 
Thus, as has been suggested for other systems and species, 
ingrowing mammalian cortical axons may have a hierarchy 
of substrate preferences (Berlot and Goodman, 1984; Toma- 
selli et al., 1986). The spatiotemporal regulation of substrate 
hierarchy could dictate whether axons wait within the sub- 
plate, or grow into the cortical plate. 
Among other developing axonal systems known to wait in 
the subplate are the cortical association and callosal systems 
that connect regions of the cerebral cortex (Wise and Jones, 
1978; Innocenti,  1981; Olavarria and Van Sluyters,  1985). 
Axons belonging to both of these systems are known to un- 
dergo rather extensive remodeling through the elimination of 
transient collaterals, some of which occurs during the wait- 
ing period (Innocenti and Caminiti, 1980; Innocenti, 1981; 
O'Leary et al.,  1981; Ivy and Killackey, 1982; reviewed by 
Stanfield, 1984). The mechanism for this elimination is not 
known but it has been suggested that macrophage-like micro- 
glia may be capable of phagocytosing the unwanted transient 
collaterals (Ling, 1976; Innocenti et al., 1983a, b; Killackey, 
1984).  These glial cells are transitory, and have been ob- 
served in many parts of the brain, including the developing 
cerebral white matter (subplate)  of at least several  species, 
including mouse (Perry et al., 1985), rat (Ling, 1976, 1977; 
Valentino and Jones, 1981), and man (Kershman, 1939; Choi, 
1981). In the postnatal cat brain, these glial cells are located 
in the same regions (Innocenti et al., 1983a, b) as the islands 
of FN immunostaining reported here. 
The spatiotemporal association between the microglia and 
FN immunostaining suggests  other functions for FNs,  at 
least during neonatal life: recruiting microglia and promot- 
ing phagocytosis. It is possible that proteolytic fragments of 
FNs produced in the subplate during the neonatal period of 
collateral retraction and subplate neuron disappearance at- 
tract microglia in a manner similar to that known to occur 
for blood monocytes (Norris et al.,  1982). This suggestion 
is  not  unreasonable,  since  in  lineage  the  microglia  are 
thought to  derive  from  blood  monocytes (Valentino  and 
Jones,  1981; Perry et al.,  1985; Esiri and Mcgee, 1986). It 
is also known that FNs and fragments can serve as opsonins 
in stimulating phagocytosis by macrophages (Gudewicz et 
al., 1980; Czop et al., 1985). Thus, elements of the subplate 
associated with FNs such as the subplate neurons or the un- 
wanted axon collaterals could be preferentially removed by 
microglial phagocytosis. 
We have suggested possible roles for FNs during cerebral 
cortical development. While such roles are speculative, the 
fact remains that FNs appear to be localized within a special 
embryonic zone in which coexist cellular interactions char- 
acteristic of the mature nervous system, as well as those as- 
sociated with the developing nervous system (neurons and 
synapses on the one hand, versus migrating neurons, grow- 
ing axons, and radial glia on the other). The extracellular 
milieu established by FNs (or similar molecules) thus corre- 
lates spatially and temporally with these interactions, and 
may be critical in allowing them to occur within the subplate 
(and marginal zone). From previous related studies, the sub- 
plate is likely also to contain extracellular matrix molecules 
known as glycosaminoglycans (i.e., hyaluronidase-sensitive 
anionic binding sites;  Nakanishi, 1983), which could main- 
tain extracellular spaces (Bondareff and Pysh, 1968; Sumi, 
1969; Cragg,  1975, 1979; Nakanishi,  1983) through which 
migration and elongation are facilitated. Further, the pres- 
ence of synapses in the subplate suggests that there may be 
other matrix molecules important to the formation and main- 
tenance of synaptic sites,  as is thought to occur at the neu- 
romuscular junction (Fallon et  al.,  1985; Wallace  et al., 
1985).  Thus,  in the formation of the mammalian cerebral 
cortex, a variety of extracellular matrix molecules, one of 
which appears to be FN, could mediate the cellular inter- 
actions unique to the subplate and marginal zones. 
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